Dr. Klint Rose co-founded Purigen Biosystems in 2012. Dr. Rose was previously an R&D Manager at QuantaLife, Inc. (acquired by Bio-Rad), where he played a key leadership role in the development, launch, and support of their droplet digital PCRTM product. He previously directed a portfolio of several successful projects at Lawrence Livermore National Laboratory (LLNL) with applications in sample preparation, desalination, and nanomanufacturing. Dr. Rose is an expert in microfluidics and electrokinetics, with over 15 years of experience in the space. Klint received his B.S. and M.S. in mechanical engineering from the Massachusetts Institute of Technology (MIT) and his Ph.D. from Stanford University.